Cytotoxic T cells targeting lytic KSHV gene products infiltrate Kaposi sarcoma tumors
Shashidhar Ravishankar, Andrea M. H. Towlerton, Iyabode L. Tiamiyu, Chris P. Miller, Peter Mooka, Janet Nankoma, James Kafeero, Dennis Mubiru, Semei Buwambaza Sekitene, Lauri D. Aicher, David Glen Coffey, Lazarus Okoche, Prisca Atwinirembabazi, Joseph Okonye, Kelvin Roland Mubiru, , Edus Houston Warren
The paper identifies KSHV-specific T-cell receptors in KS tumors, showing they recognize lytic KSHV gene products and could inform immunotherapies.
bioRxiv · Jun 9, 2026 · PreprintImmunology